Log in | Register

What’s new in cardiorenal syndrome?

Michael Darmon| Miet Schetz
What's New in Intensive Care
Volume 44, Issue 6 / June , 2018

Pages 908 - 910

No abstract available.

References

  1. Schefold JC, Filippatos G, Hasenfuss G et al (2016) Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol 12:610–623. https://doi.org/10.1038/nrneph.2016.113
    • View reference on publisher's website
    • View reference on PubMed
  2. Haase M, Müller C, Damman K et al (2013) Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:99–116. https://doi.org/10.1159/000349969
    • View reference on publisher's website
    • View reference on PubMed
  3. Dar O, Cowie MR (2008) Acute heart failure in the intensive care unit: epidemiology. Crit Care Med 36:S3–S8. https://doi.org/10.1097/01.CCM.0000296264.41365.80
    • View reference on publisher's website
    • View reference on PubMed
  4. Chen C, Lee J, Johnson AE et al (2017) Right ventricular function, peripheral edema, and acute kidney injury in critical illness. Kidney Int Rep 2:1059–1065. https://doi.org/10.1016/j.ekir.2017.05.017
    • View reference on publisher's website
    • View reference on PubMed
  5. Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51:300–306. https://doi.org/10.1016/j.jacc.2007.09.043
    • View reference on publisher's website
    • View reference on PubMed
  6. Grande D, Terlizzese P, Iacoviello M (2017) Role of imaging in the evaluation of renal dysfunction in heart failure patients. World J Nephrol 6:123–131. https://doi.org/10.5527/wjn.v6.i3.123
    • View reference on publisher's website
    • View reference on PubMed
  7. van Vark LC, Lesman-Leegte I, Baart SJ et al (2017) Prognostic value of serial ST2 measurements in patients with acute heart failure. J Am Coll Cardiol 70:2378–2388. https://doi.org/10.1016/j.jacc.2017.09.026
    • View reference on publisher's website
    • View reference on PubMed
  8. Shirakabe A, Hata N, Kobayashi N et al (2018) Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure. ESC Heart Fail. https://doi.org/10.1002/ehf2.12264
    • View reference on PubMed
  9. Brisco MA, Zile MR, Hanberg JS et al (2016) Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial. J Card Fail 22:753–760. https://doi.org/10.1016/j.cardfail.2016.06.423
    • View reference on publisher's website
    • View reference on PubMed
  10. Vaduganathan M, Greene SJ, Fonarow GC et al (2014) Hemoconcentration-guided diuresis in heart failure. Am J Med 127:1154–1159. https://doi.org/10.1016/j.amjmed.2014.06.009
    • View reference on publisher's website
    • View reference on PubMed
  11. Ahmad T, Jackson K, Rao VS et al (2018) Worsening renal function in acute heart failure patients undergoing aggressive diuresis is not associated with tubular injury. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.117.030112
  12. Legrand M, De Berardinis B, Gaggin HK et al (2014) Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. PLoS One 9:e112313. https://doi.org/10.1371/journal.pone.0112313
    • View reference on publisher's website
    • View reference on PubMed
  13. Damman K, Valente MAE, van Veldhuisen DJ et al (2017) Plasma neutrophil gelatinase-associated lipocalin and predicting clinically relevant worsening renal function in acute heart failure. Int J Mol Sci. https://doi.org/10.3390/ijms18071470
    • View reference on PubMed
  14. Maisel AS, Wettersten N, van Veldhuisen DJ et al (2016) Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol 68:1420–1431. https://doi.org/10.1016/j.jacc.2016.06.055
    • View reference on publisher's website
    • View reference on PubMed
  15. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975. https://doi.org/10.1002/ejhf.592
    • View reference on publisher's website
    • View reference on PubMed
  16. Ishihara S, Gayat E, Sato N et al (2016) Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure. Clin Res Cardiol 105:971–980. https://doi.org/10.1007/s00392-016-1009-6
    • View reference on publisher's website
    • View reference on PubMed
  17. Fedele F, Karason K, Matskeplishvili S (2017) Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan. Eur Heart J Suppl 19:C22–C28. https://doi.org/10.1093/eurheartj/sux002
    • View reference on publisher's website
    • View reference on PubMed
  18. Grodin JL, Stevens SR, de Las Fuentes L et al (2016) Intensification of medication therapy for cardiorenal syndrome in acute decompensated heart failure. J Card Fail 22:26–32. https://doi.org/10.1016/j.cardfail.2015.07.007
    • View reference on publisher's website
    • View reference on PubMed
  19. McMurray JJV, Packer M, Desai AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004. https://doi.org/10.1056/NEJMoa1409077
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement